Skip to content

AIM ImmunoTech Inc.

AIM· NYSECore metricsCIK 946644

Biological products, except diagnostic substances175 peers

Last sale
Nov 12, 2026 · -0.48%
Market cap
$5.83M
39.92M shares
Filings
1,040
$22.00K
Q3 2026−48.2% FY25 yoy
-$3.14M
Q3 2026N/M FY25 yoy
-$2.96M
Q3 2026N/M FY25 yoy
-$14.91M
FY 2024derivedN/M FY24 yoy
-$0.21
Q3 2026N/M FY25 yoy
$6.89M
Q3 2026+75.5% FY25 yoy
$5.83M
—
64.0×
0.8×
—
—

Twelve months to Sep 30, 2026 · derived

Price

$0.14690.76%$1.434past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$88.00KFY 2025
$437.00K0FY 2014FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$88,000reported
FY 20242024-12-31$170,000reported
FY 20232023-12-31$202,000reported
FY 20222022-12-31$141,000reported
FY 20212021-12-31$135,000reported
FY 20202020-12-31$163,000reported
FY 20192019-12-31$140,000reported
FY 20182018-12-31$367,000reported
FY 20172017-12-31$437,000reported
FY 20162016-12-31$92,000reported
FY 20152015-12-31$133,000reported
FY 20142014-12-31$197,000reported

Segments

Revenue by Geography, FY2019 to FY2020FY2019United States · FY2019 · $110.00KEurope · FY2019 · $30.00KFY2020United States · FY2020 · $144.00KEurope · FY2020 · $19.00K
LineFY2020ShareChange
United States$144.00K88%+30.9%
Europe$19.00K12%−36.7%
Total$163.00K

From the 10-K filed Mar 31, 2021AIM

Biological products, except diagnostic substances

AIM ImmunoTech Inc. is the 85th largest of the 176 covered companies the SEC files under this code, by revenue. SIC 2836

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

AIM ImmunoTech Inc. · CIK 946644 · Engraved from SEC EDGAR